Coping of Chronically-Ill Patients during the COVID-19 Pandemic: Comparison between Four Groups

Int J Environ Res Public Health. 2023 Mar 9;20(6):4814. doi: 10.3390/ijerph20064814.

Abstract

In many countries, the COVID-19 pandemic led to healthcare reorganization limiting access to diagnostic or therapeutic procedures for chronically-ill patients. In this article, we describe the psychological consequences and coping strategies of several groups of chronically-ill patients. During the cross-sectional survey conducted in 2020, we enrolled 398 patients with four different chronic conditions (psoriasis, multiple sclerosis, and patients who have undergone a kidney transplant or received dialysis). The study sample was examined regarding the experienced stress levels (Perceived Stress Scale) and coping strategies (Brief-COPE). All four groups of patients most commonly declared using problem-focused coping strategies and least commonly reported the use of avoidant coping. Higher levels of perceived stress strongly correlated with self-blaming. The participants who declared previous psychiatric treatment or psychotherapy were more likely to use self-blaming, behavioral disengagement, substance use, and avoidant coping, while previous psychotherapy additionally correlated with emotion-focused coping. Group comparison identifies patients with a chronic neurological disease, such as multiple sclerosis, at higher risk of a less beneficial coping profile than kidney transplant recipients. Further focus on education and early interventions in at-risk individuals is needed, and widely targeted mental health programs are indicated in order to improve the mental health of patients suffering from chronic diseases.

Keywords: COVID-19; SARS-CoV-2; chronic diseases; chronic kidney disease; coping; multiple sclerosis; pandemic; psoriasis; psychopathology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Psychological
  • COVID-19* / epidemiology
  • Chronic Disease
  • Cross-Sectional Studies
  • Humans
  • Pandemics

Grants and funding

This research was funded by Wroclaw Medical University, grant number SUBZ.C230.22.062.